eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Novartis - Comment

Novartis - Comment

Document ID: FDA-2011-D-0577-0005
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 07 2011, at 12:00 AM Eastern Standard Time
Date Posted: December 16 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 15 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 14 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f66f14
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Novartis comments FDA-2010-D-0577

Title:
Novartis comments FDA-2010-D-0577

View Attachment: View as format pdf

Related Comments

    View All
Total: 15
Francisco Martinez Murillo - Comment
Public Submission    Posted: 09/27/2011     ID: FDA-2011-D-0577-0003

Nov 14,2011 11:59 PM ET
NeuroPace, Inc. - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2011-D-0577-0004

Nov 14,2011 11:59 PM ET
Novartis - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0005

Nov 14,2011 11:59 PM ET
Stephanie Bechtold - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0006

Nov 14,2011 11:59 PM ET
Roche Diagnostics - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0007

Nov 14,2011 11:59 PM ET